Skip to main content

Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial.

Publication ,  Journal Article
Al-Khatib, SM; Wojdyla, DM; Granger, CB; Wallentin, L; Garcia, DA; Hijazi, Z; Held, C; Alexander, JH; Vinereanu, D; Flaker, GC; Hylek, EM; Lopes, RD
Published in: Circulation
September 20, 2022

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

September 20, 2022

Volume

146

Issue

12

Start / End Page

958 / 960

Location

United States

Related Subject Headings

  • Warfarin
  • Humans
  • Cardiovascular System & Hematology
  • Blood Coagulation
  • Atrial Fibrillation
  • Anticoagulants
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Al-Khatib, S. M., Wojdyla, D. M., Granger, C. B., Wallentin, L., Garcia, D. A., Hijazi, Z., … Lopes, R. D. (2022). Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial. Circulation, 146(12), 958–960. https://doi.org/10.1161/CIRCULATIONAHA.122.059438
Al-Khatib, Sana M., Daniel M. Wojdyla, Christopher B. Granger, Lars Wallentin, David A. Garcia, Ziad Hijazi, Claes Held, et al. “Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial.Circulation 146, no. 12 (September 20, 2022): 958–60. https://doi.org/10.1161/CIRCULATIONAHA.122.059438.
Al-Khatib SM, Wojdyla DM, Granger CB, Wallentin L, Garcia DA, Hijazi Z, et al. Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial. Circulation. 2022 Sep 20;146(12):958–60.
Al-Khatib, Sana M., et al. “Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial.Circulation, vol. 146, no. 12, Sept. 2022, pp. 958–60. Pubmed, doi:10.1161/CIRCULATIONAHA.122.059438.
Al-Khatib SM, Wojdyla DM, Granger CB, Wallentin L, Garcia DA, Hijazi Z, Held C, Alexander JH, Vinereanu D, Flaker GC, Hylek EM, Lopes RD. Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial. Circulation. 2022 Sep 20;146(12):958–960.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

September 20, 2022

Volume

146

Issue

12

Start / End Page

958 / 960

Location

United States

Related Subject Headings

  • Warfarin
  • Humans
  • Cardiovascular System & Hematology
  • Blood Coagulation
  • Atrial Fibrillation
  • Anticoagulants
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services